ATEA PHARMACEUTICALS INC's ticker is AVIR and the CUSIP is 04683R106. A total of 126 filers reported holding ATEA PHARMACEUTICALS INC in Q1 2023. The put-call ratio across all filers is 0.50 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $369,600 | -37.5% | 123,200 | -22.1% | 0.00% | -50.0% |
| Q2 2023 | $591,294 | -7.6% | 158,100 | -17.2% | 0.00% | 0.0% |
| Q1 2023 | $639,766 | -38.2% | 190,975 | -11.3% | 0.00% | -33.3% |
| Q4 2022 | $1,035,362 | +0.5% | 215,252 | +18.9% | 0.00% | 0.0% |
| Q3 2022 | $1,030,000 | -17.3% | 181,067 | +3.1% | 0.00% | 0.0% |
| Q2 2022 | $1,246,000 | +5.3% | 175,542 | +7.2% | 0.00% | +50.0% |
| Q1 2022 | $1,183,000 | +58.4% | 163,800 | +95.9% | 0.00% | +100.0% |
| Q4 2021 | $747,000 | -74.5% | 83,600 | 0.0% | 0.00% | -83.3% |
| Q3 2021 | $2,931,000 | +63.2% | 83,600 | 0.0% | 0.01% | +50.0% |
| Q2 2021 | $1,796,000 | +44.7% | 83,600 | +315.9% | 0.00% | +33.3% |
| Q1 2021 | $1,241,000 | +47.7% | 20,100 | 0.0% | 0.00% | +50.0% |
| Q4 2020 | $840,000 | – | 20,100 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tyrus Capital S.A.M. | 1,260,000 | $4,712,400 | 33.11% |
| BML Capital Management, LLC | 2,236,239 | $8,363,534 | 7.52% |
| TANG CAPITAL MANAGEMENT LLC | 3,026,455 | $11,318,942 | 1.67% |
| Stonepine Capital Management, LLC | 752,088 | $2,812,809 | 1.02% |
| Bain Capital Life Sciences Investors, LLC | 2,485,638 | $9,296,286 | 0.96% |
| CM Management, LLC | 250,000 | $935 | 0.91% |
| EcoR1 Capital, LLC | 6,995,861 | $26,164,520 | 0.64% |
| Cormorant Asset Management, LP | 1,547,181 | $5,786,457 | 0.32% |
| SECTORAL ASSET MANAGEMENT INC | 501,537 | $1,875,748 | 0.31% |
| Auour Investments LLC | 177,000 | $661,980 | 0.28% |